drugset / Trial / NCT02446028
A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of BIOD-531 compared to Humalog®Mix 75/25 in patients with type 2 diabetes.
Timeline
- Start
- 2015-05
- Primary completion
- 2016-02
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIOD-531 | Protein / enzyme biologic | — | — |
| Comparator | Humalog®Mix 75/25 | Protein / enzyme biologic | — | — |